Namely, multiple cytokines that promote the M1-to-M2 switch (including IL-5, IL-10, IL-17, IL-22) were higher in the serum of PyMT-bearing mice independent of the presence and absence of TAC, indicating the involvement of tumor properties in inducing this switch. The gene discussed is IL22; the disease is neoplasm.